NCT03664752View on ClinicalTrials.gov

Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

585

Participants

Timeline

Start Date

December 10, 2018

Primary Completion Date

May 7, 2020

Study Completion Date

May 7, 2020

Conditions
Acne Vulgaris
Interventions
DRUG

IDP-120 Gel

IDP-120 Gel, once-daily application

DRUG

IDP-120 Vehicle Gel

IDP-120 Vehicle Gel, once-daily application

Trial Locations (20)

14623

Valeant Site 227, Rochester

27612

Valeant Site 229, Raleigh

Valeant Site 230, Raleigh

30078

Valeant Site 222, Snellville

33144

Valeant Site 202S, Miami

33437

Valeant Site 204, Boynton Beach

33511

Valeant Site 217, Brandon

33606

Valeant Site 214, Tampa

48038

Valeant Site 221, Clinton Township

48346

Valeant Site 216, Clarkston

70006

Valeant Site 205, Metairie

72758

Valeant Site 210, Rogers

78213

Valeant Site 213, San Antonio

83704

Valeant Site 215, Boise

90266

Valeant Site 201, Manhattan Beach

92123

Valeant Site 206, San Diego

Valeant Site 218, San Diego

99202

Valeant Site 223, Spokane

N2J 1C4

Valeant Site 219, Waterloo

Valeant Site 228, Waterloo

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT03664752 - Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter